Clinical Trials Logo

Filter by:
NCT ID: NCT03597763 Completed - Clinical trials for Traumatic Brain Injury

Fatigue Following Moderate and Severe TBI

Start date: March 1, 2018
Phase:
Study type: Observational

The subjective feeling of being periodically fatigued, tired, even exhausted is common in the general population, as well as in a large number of medical conditions, including neurological illness, such as traumatic brain injury (TBI), cerebrovascular accidents (CVA), multiple sclerosis (MS), and poliomyelitis. Fatigue typically results in compensatory behaviors such as spending extended time in bed, daytime napping, and restricted participation in activities of daily living, which in turn can have a profound negative impact on mental and physical health. Although fatigue is common and debilitating, there is a scarcity of knowledge concerning underlying biological, psychological and psychosocial mechanisms in the development and maintenance of persisting fatigue. There is also a general lack of theoretical accounts of potentially shared and etiology-specific mechanisms across conditions. The existence of clinical subgroups and diverse clinical trajectories is not well documented, resulting in a lack of evidence-based treatment opportunities. Diagnosis and management of fatigue is further challenged by difficulties in conceptualizing and defining the phenomenon itself, since fatigue is subjectively experienced and multifaceted. Thus, as fatigue often poses a chronic problem, health professionals in community based rehabilitation settings are faced with helping patients cope with this symptom without a clear understanding of causes or treatment options. The current project aims to map the occurrence of fatigue following moderate to severe TBI and achieve a better theoretical and clinical understanding of the mechanisms which may cause, exacerbate or protect against persisting fatigue following TBI. The study approach acknowledges that fatigue after neurological illness is the result of complex interplays between general individual predispositions and etiology-specific factors. A better understanding of these mechanisms is a prerequisite for personalized treatment and development of empirically based randomized controlled intervention studies. This approach has relevance to other clinical conditions as well. The long-term aim is to ensure accurate diagnosis, improve treatment and rehabilitation, and to contribute to knowledge based clinical decision-making both within specialized and community based rehabilitation settings.

NCT ID: NCT03597295 Completed - Clinical trials for Squamous Cell Carcinoma of Anal Canal

A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)

Start date: October 8, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy of INCMGA00012 in participants with locally advanced or metastatic squamous carcinoma of the anal canal (SCAC) who have progressed after platinum-based chemotherapy.

NCT ID: NCT03594344 Recruiting - Diabetes Mellitus Clinical Trials

Additional Hyperbaric Oxygen After Lower Extremity Amputation

AHOLEA
Start date: July 4, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

NCT ID: NCT03593798 Completed - Physical Capacity Clinical Trials

Lifestyle Intervention and Physical Capacity in Patients With Morbid Obesity

LEICO
Start date: November 1, 2013
Phase:
Study type: Observational

Lifestyle intervention and physical capacity in patients with morbid Obesity (LEICO)

NCT ID: NCT03593148 Recruiting - Eating Behavior Clinical Trials

The Effect of Lifestyle Treatment in Patients With Morbid Obesity

LIFETIME
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The effect of lifestyle treatment on physical capacity, maximal strength, eating behavior and quality of life in patients with morbid obesity (LIFETIME)

NCT ID: NCT03590171 Recruiting - Clinical trials for Acute Lymphoblastic Leukemia (ALL)

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

Start date: September 1, 2017
Phase: Phase 2
Study type: Interventional

The main goal of this study is to improve the outcome of children and adolescents with acute lymphoblastic leukemia with high risk first relapse by optimization of treatment strategies within a large international trial and the integration of new agents.

NCT ID: NCT03581604 Recruiting - Allergy Drug Clinical Trials

De-labeling of Patients With False Diagnosis of Penicillin Allergy

Start date: September 13, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to estimate the prevalence of penicillin allergy, evaluate the diagnostic value of the allergologic work-up used in the study, and the health effects of penicillin allergy.

NCT ID: NCT03580655 Active, not recruiting - Mast Cell Leukemia Clinical Trials

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

Start date: November 21, 2018
Phase: Phase 2
Study type: Interventional

This is an open-label, single arm, Phase 2 study evaluating the efficacy and safety of avapritinib (BLU-285) in patients with advanced systemic mastocytosis (AdvSM), including patients with aggressive SM (ASM), SM with associated hematologic neoplasm (SM-AHN), and mast cell leukemia (MCL)

NCT ID: NCT03580213 Completed - Clinical trials for Dupuytren Disease of Palm and Finger, With Contracture

Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?

Start date: April 5, 2018
Phase: N/A
Study type: Interventional

This study evaluates if hand therapy have an impact on the patients' preformance of and satisfaction with everyday activities or not following collagenase injection treatment for Dupuytren's contracture. Differences on this between patients with contracted proximal interphalangeal joint(s) and patients with affected metacarpophalangeal joint(s) only, will also be investigated. Two equal sized groups will either receive hand therapy or no treatment following the injection and extension procedure.

NCT ID: NCT03580057 Completed - Clinical trials for Cardiovascular Risk Factor

Effect of Weight Loss and Lactation (the EVA-trial)

EVA
Start date: January 30, 2018
Phase: N/A
Study type: Interventional

A randomized controlled trial aiming to investigate the effects and possible interactions of diet induced weight loss and lactation on cardiometabolic profile